Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

CYCN
Cyclerion Therapeutics, Inc. Common Stock
stock NASDAQ

At Close
Jun 6, 2025 3:15:25 PM EDT
3.20USD+0.946%(+0.03)15,153
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jun 4, 2025 9:05:30 AM EDT
3.21USD+1.262%(+0.04)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
9.81M
Industry
Biotechnology
Last Split
May 16, 20231for20reverse
CYCN Stats
Avg. Vol. 10 Day
24,045
Avg. Vol. 30 Day
19,796
Employees
16
Market Cap
9,810,326
Shares Out.
3,060,944
On/Off Exchange
29%/71%
6 Month Beta
0.02
1 Year Beta
0.45
2 Year Beta
0.24
3 Year Beta
0.28
52 Week Low
1.27
52 Week High
9.47
SMA50
2.95
SMA200
2.90
1 Week
+8.28%
1 Month
+1.50%
3 Month
+14.46%
6 Month
-20.86%
1 Year
+25.69%
2 Year
-26.49%
5 Year
-96.94%
Profile
cyclerion therapeutics, inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of various treatments for serious and orphan diseases. its product candidates include olinciguat, an orally administered vascular soluble guanylate cyclase (sgc) stimulator that is in phase ii studies for the treatment of sickle cell disease (scd); praliciguat, an orally administered systemic sgc stimulator that is in phase ii trials for the treatment of diabetic nephropathy and heart failure with preserved ejection fraction; and iw-6463, an orally administered central nervous system (cns)-penetrant sgc stimulator, which is in phase i trials for neurodegenerative diseases. the company is also discovering liver-targeted sgc and lung-targeted sgc stimulators. cyclerion therapeutics, inc. was incorporated in 2018 and is headquartered in cambridge, massachusetts.

CYCN Stock Summary

Cyclerion Therapeutics, Inc. Common Stock (NASDAQ:CYCN) stock price today is $3.20, and today's volume is 15,153. CYCN is up 0.946% today. The 30 day average volume is 19,796. CYCN market cap is 9.81M with 3,060,944 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC